Irritable Bowel Syndrome and the Elusive Mast Cells

被引:12
|
作者
Theoharides, Theoharis C. [1 ,2 ,3 ,4 ,6 ]
Asadi, Shahrzad [1 ,5 ]
Chen, Jihong [7 ]
Huizinga, Jan D. [8 ]
机构
[1] Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Mol Immunopharmacol & Drug Discovery Lab, Boston, MA 02111 USA
[2] Tufts Univ, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA
[3] Tufts Univ Sch, Dept Biochem, Boston, MA USA
[4] Tufts Univ, Sch Med, Dept Internal Med, Boston, MA 02111 USA
[5] Tufts Med Ctr, Dept Pharm, Boston, MA USA
[6] Tufts Univ, Sch Med, Dept Psychiat, Boston, MA 02111 USA
[7] Wuhan Univ, Dept Gastroenterol, Renmin Hosp, Wuhan 430072, Peoples R China
[8] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2012年 / 107卷 / 05期
基金
加拿大健康研究院;
关键词
ENDOTHELIAL GROWTH-FACTOR; DIFFERENTIAL RELEASE; ACUTE STRESS; ACTIVATION; IBS;
D O I
10.1038/ajg.2012.61
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Irritable bowel syndrome (IBS) is the most common condition seen by gastroenterologists. It presents with alternating symptoms of bowel dysfunction that often worsens with stress. The cause of these symptoms eludes investigators and many attempts have been made to discover an underlying pathology. This is a daunting task since symptoms come and go, and change characteristics. Furthermore, the pathology of IBS is unlikely to be identical in all patients. In addition, all symptoms and all features studied thus far have a strong overlap with healthy volunteers. Elsewhere in this issue, Braak et al. report a well-designed clinical investigation in patients with IBS and come to the conclusion that IBS is not characterized by mast cell or other immune cell proliferation, but by immune dysregulation in the colon. Is this the final answer?
引用
收藏
页码:727 / 729
页数:3
相关论文
共 50 条
  • [1] Increased mast cells in the irritable bowel syndrome
    O'Sullivan, M
    Clayton, N
    Breslin, NP
    Harman, I
    Bountra, C
    McLaren, A
    O'Morain, CA
    NEUROGASTROENTEROLOGY AND MOTILITY, 2000, 12 (05): : 449 - 457
  • [2] Colonic mast cells in irritable bowel syndrome
    Park, CH
    Joo, YE
    Choi, SK
    Rew, JS
    Kim, SJ
    Lee, MC
    GASTROENTEROLOGY, 2002, 122 (04) : A552 - A552
  • [3] The Role of Mast Cells in Irritable Bowel Syndrome
    Lee, Kang Nyeong
    Lee, Oh Young
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2016, 2016
  • [4] Mast Cells in Irritable Bowel Syndrome: A Systematic Review
    Krammer, Luisa
    Sowa, Anna Sergeevna
    Lorentz, Axel
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2019, 28 (04) : 463 - +
  • [5] ELUSIVE IRRITABLE-BOWEL SYNDROME
    ROSEN, LW
    GREENBAU.DS
    FERGUSON, RK
    KATER, LA
    KUIPER, DH
    NEW ENGLAND JOURNAL OF MEDICINE, 1973, 288 (15): : 796 - 796
  • [6] Irritable bowel syndrome - An inflammatory disease involving mast cells
    Philpott, Hamish
    Gibson, Peter
    Thien, Frank
    ASIA PACIFIC ALLERGY, 2011, 1 (01) : 36 - 42
  • [7] Increased mucosal mast cells in irritable bowel syndrome (IBS).
    O'Sullivan, M
    Breslin, NP
    Harman, I
    Clayton, N
    Bountra, C
    McLaren, A
    O'Morain, CA
    GASTROENTEROLOGY, 1998, 114 (04) : A816 - A816
  • [8] Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside
    Zhang, Lei
    Song, Jun
    Hou, Xiaohua
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 22 (02) : 181 - 192
  • [9] Mast cells and nerves tickle in the tummy implications for inflammatory bowel disease and irritable bowel syndrome
    Rijnierse, Anneke
    Nijkamp, Frans P.
    Kraneveld, Aletta D.
    PHARMACOLOGY & THERAPEUTICS, 2007, 116 (02) : 207 - 235
  • [10] Translocation in Irritable Bowel Syndrome: Mast Cells and VIP play important Roles
    Franke, Katharina
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2018, 56 (02): : 102 - 102